A GSK Case Study: Supporting Both HTS And Multiple Hit Strategies With Flexible Processes

Posted: 07/01/2010
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.


Lola Jimenez-Alfaro, Manager of Sample Management Technologies, GlaxoSmithKline, discusses running an effective compound management lab to support hit discovery activities, at IQPC's 7th Annual Compound Management & Integrity conference.



Jimenez-Alfaro discusses:
 

  • Running an effective compound management lab to support hit discovery activities
  • Exploiting cutting-edge technology for increased quality, performance and capability
  • Supplying the same quantity of compounds while ensuring the same level of quality
  • Keeping up with the demands of customers to deliver focused screening sets
  • Adapting our processes with customers to provide "customised sets" with often different plate and compound formats
  • Next steps for Sample Management at Tres Cantos and GSK Europe
Contributor: